Loading...
XJPX
4021
Market cap7.66bUSD
Oct 09, Last price  
9,090.00JPY
1D
0.78%
1Q
12.22%
Jan 2017
132.78%
Name

Nissan Chemical Corp

Chart & performance

D1W1MN
XJPX:4021 chart
P/E
24.52
P/S
4.36
EPS
370.65
Div yield, %
1.93%
Shrs. gr., 5y
-1.35%
Rev. gr., 5y
5.98%
Revenues
279.59b
+11.23%
174,351,000,000169,172,000,000160,162,000,000149,036,000,000154,209,000,000148,578,000,000153,806,000,000163,658,000,000171,206,000,000176,894,000,000180,289,000,000193,389,000,000204,896,000,000206,837,000,000209,121,000,000207,972,000,000228,065,000,000226,705,000,000251,365,000,000279,586,000,000
Net income
49.71b
+15.49%
13,992,000,00015,503,000,00010,052,000,00012,751,000,00012,953,000,00010,975,000,00013,879,000,00016,701,000,00018,199,000,00022,350,000,00024,026,000,00027,143,000,00029,373,000,00030,780,000,00033,470,000,00038,777,000,00041,088,000,00038,034,000,00043,042,000,00049,708,000,000
CFO
64.16b
+8.43%
19,760,000,00018,973,000,00014,635,000,00026,575,000,00024,914,000,00021,903,000,00022,839,000,00023,759,000,00020,452,000,00029,989,000,00032,491,000,00037,691,000,00032,070,000,00035,550,000,00039,939,000,00041,949,000,00035,226,000,00033,701,000,00059,178,000,00064,164,000,000
Dividend
Mar 30, 2027142 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Founded in Tokyo in 1887, Nissan Chemical Corporation conducts its diverse business operations both domestically in Japan and across international markets, specializing in four key areas: chemicals, performance materials, agricultural chemicals, and pharmaceuticals. The company's expansive chemical product line includes the adhesive agent MELAMINE, a variety of high-purity chemicals, the urea solution AdBlue, and foundational industrial compounds such as ammonia, sulfuric acid, and nitric acid. Other specialized chemical offerings feature TEPIC (an epoxy compound), Melamine Cyanurate (a salt of melamine and isocyanuric acid), phenylphosphonic acid, and HI-LITE (a chlorinated isocyanurate). Additionally, Nissan Chemical manufactures the health food Nissan Reishi, OPTBEADS (composed of melamine-formaldehyde resin and silica), and FINEOXOCOL (a saturated fatty alcohol and acid). Within its performance materials division, the corporation develops crucial materials for display technologies, semiconductors, and various inorganic applications. Its agricultural chemicals segment supplies a broad range of products, including herbicides, insecticides, and fungicides, utilized on farmlands, golf courses, and public parks. This division also produces active pharmaceutical ingredients for animal antiparasitic medications. In the pharmaceutical sector, Nissan Chemical markets prescription drugs such as LIVALO, which is used to reduce cholesterol, and LANDEL and FINTE, both dual-action calcium channel blockers. Beyond its proprietary pharmaceutical products, the company offers custom manufacturing and process research services for pharmaceutical ingredients. Looking towards future innovation, Nissan Chemical is actively engaged in developing solutions across healthcare, information and communication materials, and environmental and energy materials. The company, which was previously known as Nissan Chemical Industries, Ltd., officially changed its name to Nissan Chemical Corporation in July 2018.

Key people

Hideyuki Endo
Managing Executive Officer, Chief Technology Officer, Chief Director of Planning · since 2023
Hideki Daimon
Vice President, Senior Managing Executive Officer, Chief Financial Officer, Director of Finance, Director · since 2025
Motoaki Ishikawa
Senior Managing Executive Officer, Director of Functional Materials Business, Chairman of Subsidiaries, Director · since 2022
Yuji Sato
Senior Managing Executive Officer, Director of Agricultural Chemicals Business, Chairman of Subsidiaries, Director · since 2025
Satoshi Kageshima
Managing Executive Officer, Director of Intellectual Property · since 2025
Takeshi Matsuoka
Managing Executive Officer, Chief Risk Officer, Director of Business Planning, Director · since 2022
Norihisa Ishiwata
Executive Officer, Director of Healthcare Business · since 2022
Wataru Kawashima
Executive Officer, Director of Human Resources, Manager of Health Promotion Office in Human Resources Unit · since 2021
Eiji Komatsu
Executive Officer, Chief Director of Sales in Agricultural Chemicals Business Unit, Deputy Director of Business in Agricultural Chemicals Business Unit · since 2023
Teruyuki Koshi
Executive Officer, Director of Environment, Safety and Quality Assurance · since 2025
Jun Murakawa
Executive Officer, Sodegaura Plant Manager, Manager of Goi Manufacturing Center in Sodegaura Plant · since 2025
Akihiro Nakagawa
Executive Officer, Toyama Plant Manager · since 2023
Takayasu Nihira
Executive Officer, Director of Materials Science Research Institute · since 2023
Toshio Niki
Executive Officer, Director of Biological Sciences Research Institute · since 2025
Toshiaki Okikawa
Executive Officer, Director of Chemicals Business · since 2022
Naoki Yamamoto
Executive Officer, Onoda Plant Manager · since 2024
Shinsuke Yagi
President, Chief Operating Officer, Representative Director · since 2021
Itsuo Hama
Independent Director · since 2025
Independent Director · since 2025
Kazunori Kataoka
Independent Director · since 2020
IPO date
May 16, 1949
Employees
2,965
Domiciled in
JP
Incorporated in
JP
Headquarters & legal address
日本橋二丁目5番1号
東京都 中央区 103-6119
JP
Address
5-1, Nihonbashi 2-chome
Chuo-ku Tokyo 103-6119
JP
Other language
Nissan Chemical Corporation

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT